Our study found for the first time that some antihypertensive drugs with central action (clonidine), α and β blockers (carvedilol and labetalol), renin inhibitors (aliskiren), and vasodilators (hydralazine and nitroglycerin) were associated with increased risk of hyperuricaemia, gout or related AEs. This evidence concerns the gene REN and hyperuricemia.